BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8271402)

  • 21. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
    Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
    J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIDS 1995. Virology: overview.
    Fenyö EM; Rosen CA
    AIDS; 1995; 9 Suppl A():S1-3. PubMed ID: 8819564
    [No Abstract]   [Full Text] [Related]  

  • 23. RNA-sequence-mediated gene regulation in HIV-1.
    Cullen BR
    Infect Agents Dis; 1994; 3(2-3):68-76. PubMed ID: 7812657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV gene regulatory proteins tat and rev and their interactions with synthetic RNA.
    Asseline U; Grasby J; Hamy F; Iwai S; Mann DA; Pritchard C; Karn J; Gait MJ
    Nucleic Acids Symp Ser; 1993; (29):113-4. PubMed ID: 7504239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of HIV replication].
    Adachi A; Yamamoto Y; Sone S
    Uirusu; 1996 Dec; 46(2):145-54. PubMed ID: 9123886
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anti-HIV compounds].
    Kiso Y; Kisanuki S
    Nihon Rinsho; 1993 Sep; 51 Suppl():235-40. PubMed ID: 8271390
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic approaches to HIV infection based on virus structure and the host pathogen interaction.
    Pauza CD; Streblow DN
    Curr Top Microbiol Immunol; 1995; 202():117-32. PubMed ID: 7587359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open label, phase I/II clinical trial to evaluate the safety and biological activity of HIV-IT (V) (HIV-1IIIBenv/rev retroviral vector) in HIV-1-infected subjects.
    Haubrich R; McCutchan JA; Holdredge R; Heiner L; Merritt J; Merchant B
    Hum Gene Ther; 1995 Jul; 6(7):941-55. PubMed ID: 7578412
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.
    Connolly KJ; Hammer SM
    Antimicrob Agents Chemother; 1992 Mar; 36(3):509-20. PubMed ID: 1377897
    [No Abstract]   [Full Text] [Related]  

  • 30. A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme.
    Amado RG; Mitsuyasu RT; Symonds G; Rosenblatt JD; Zack J; Sun LQ; Miller M; Ely J; Gerlach W
    Hum Gene Ther; 1999 Sep; 10(13):2255-70. PubMed ID: 10498256
    [No Abstract]   [Full Text] [Related]  

  • 31. Gene therapy for the treatment of AIDS: animal models and human clinical experience.
    Amado RG; Mitsuyasu RT; Zack JA
    Front Biosci; 1999 May; 4():D468-75. PubMed ID: 10331991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HIV superinfection].
    Kishi M; Ikuta K
    Nihon Rinsho; 1993 Sep; 51 Suppl():598-603. PubMed ID: 8271445
    [No Abstract]   [Full Text] [Related]  

  • 33. [CD4-derivatives therapy of HIV carriers].
    Mizukami T; Mitsuya H
    Nihon Rinsho; 1993 Sep; 51 Suppl():327-33. PubMed ID: 8271399
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunotherapy for HIV carrier].
    Gohchi K; Matsuda J
    Nihon Rinsho; 1993 Sep; 51 Suppl():338-42. PubMed ID: 7505850
    [No Abstract]   [Full Text] [Related]  

  • 35. New molecular tool may lead to a new class of drugs.
    McCarthy M
    Lancet; 1999 Jun; 353(9170):2134. PubMed ID: 10382709
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection.
    Smythe JA; Symonds G
    Inflamm Res; 1995 Jan; 44(1):11-5. PubMed ID: 7664023
    [No Abstract]   [Full Text] [Related]  

  • 37. Ribozymes enter clinical trials for HIV-1 treatment.
    Rowe PM
    Lancet; 1996 Nov; 348(9037):1302. PubMed ID: 8909386
    [No Abstract]   [Full Text] [Related]  

  • 38. [Targets and possible therapeutic interventions for HIV carriers].
    Kageyama S; Kurimura T
    Nihon Rinsho; 1993 Sep; 51 Suppl():351-6. PubMed ID: 8271402
    [No Abstract]   [Full Text] [Related]  

  • 39. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
    Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
    Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of expression of human immunodeficiency virus.
    Pavlakis GN; Felber BK
    New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.